Macro
YS Biopharma reports positive data from Covid-19 vaccine trial
YS Biopharma has reported positive interim data from Phase II part of the Phase II/III head-to-head clinical study of its…
Atea Pharmaceuticals announces results of bemnifosbuvir for Covid-19
Atea Pharmaceuticals has announced new Phase I in vitro and in vivo results demonstrating the favourable profile attributes of bemnifosbuvir…
BWH’s investigators test Foralumab in pilot trial for Covid-19
Investigators from Brigham and Women’s Hospital (BWH) have tested the nasal administration of Foralumab, an anti-CD3 monoclonal antibody, as part…
Insilico Medicine to commence trials of ISM3312 in China to treat Covid-19
Insilico Medicine has announced plans to commence clinical trials of its orally available 3CLpro inhibitor ISM3312 in China for the…
eFFECTOR reports positive data from trial of zotatifin for Covid-19
eFFECTOR Therapeutics has reported positive top-line data from its Phase Ib clinical trial of zotatifin to treat Covid-19. The potent…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
RVAC Medicines receives HSA approval for Covid-19 mRNA vaccine trial
RVAC Medicines has received approval from the Health Sciences Authority (HSA) to commence the Phase IB clinical trial of three…
GeoVax and EmVenio partner for clinical facility to expand Covid-19 trial
GeoVax Labs and decentralised trial global organisation EmVenio Research have announced a partnership for the deployment of a mobile clinical…
What might the end of the Covid-19 emergency mean for the drug development pipeline?
US President Joe Biden reiterated in his State of the Union speech on 7 February that the country will end…
MediciNova gains approval from Health Canada for long Covid therapy trial
MediciNova has received authorisation from Health Canada to initiate the multi-arm Phase II/III clinical trial of MN-166 (ibudilast) to treat…
GreenLight receives Rwanda FDA approval for Covid-19 mRNA vaccine trial
GreenLight Biosciences has received the Rwanda Food and Drugs Authority (Rwanda FDA) approval for a Phase I/II clinical trial of…